0.53
TriSalus Life Sciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
17.2
FY23:
20.9
FY24:
20.7
FY25:
32.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
250
FY22:
4.78
FY23:
3.74
FY24:
3.30
FY25:
3.09
Total assets
Change from FY21 to FY25
millions USD
FY21:
251
FY22:
22.0
FY23:
24.6
FY24:
24.0
FY25:
35.3
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.60
FY22:
32.4
FY23:
14.7
FY24:
10.2
FY25:
11.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
15.6
FY22:
1.96
FY23:
37.0
FY24:
39.6
FY25:
57.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.7
FY22:
−176
FY23:
−27.1
FY24:
−25.9
FY25:
−33.9
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
24.6
FY24:
24.0
FY25:
35.3
All amounts in millions USD